Neurocrine Biosciences reported $3.1M in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4499M 307M
Acadia Pharmaceuticals ACAD:US $ 5.21M 0.51M
Acorda Therapeutics ACOR:US $ 11.32M 0.64M
Adamas Pharmaceuticals ADMS:US 527K 142K
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
ALKERMES ALKS:US 53.12M 12.1M
Alnylam Pharmaceuticals ALNY:US $ 30.26M 7.23M
Amgen AMGN:US $ 1637M 147M
Biogen BIIB:US $ 459.7M 18.4M
Biomarin Pharmaceutical BMRN:US $ 127.06M 6.9M
Dynavax Technologies DVAX:US $ 14.84M 9.78M
Exelixis EXEL:US $ 14.88M 1.69M
Gilead Sciences GILD:US $ 1390M 29M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Halozyme Therapeutics HALO:US $ 23.02M 4.8M
Intercept Pharmaceuticals ICPT:US $ 0.62M 0.19M
Intra Cellular Therapies ITCI:US $ 2.04M 0.58M
IONIS PHARMACEUT IONS:US $ 2.96M 0.38M
Nektar Therapeutics NKTR:US $ 7.67M 1.91M
Neurocrine Biosciences NBIX:US $ 3.1M 0.2M
Pfizer PFE:US $ 6992M 2820M
Regeneron Pharmaceuticals REGN:US $ 693.7M 385.7M
Repligen RGEN:US $ 61.99M 2.24M
Rigel Pharmaceuticals RIGL:US $ 0.13M 0.19M
Sarepta Therapeutics SRPT:US $ 19.52M 2.83M
Teva Pharmaceutical TEVA:IT 1.99B 76M
Ultragenyx Pharmaceutical RARE:US $ 3.14M 2.05M
Vertex Pharmaceuticals VRTX:US $ 227.97M 35.64M
YTE INCY:US $ 32.63M 8.81M
Zogenix ZGNX:US $ 1.22M 0.55M